Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 8/20 | 0.48 |
| ▸ | MAOA | P21397 | 7/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 6/20 | 0.48 |
| ▸ | KDM1A | O60341 | 5/20 | 0.48 |
| ▸ | CYP2B6 | P20813 | 3/20 | 0.48 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.48 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.48 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.48 |
| ▸ | HTR1A | P08908 | 2/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.48 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.48 |
| ▸ | HTR2C | P28335 | 1/20 | 0.48 |
| ▸ | DRD3 | P35462 | 1/20 | 0.48 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4171085 | 1.00 | MAOB (0.48) | MAOBMAOACYP2C19KDM1ACYP2B6 | |
| SCHEMBL4171082 | 1.00 | MAOB (0.48) | MAOBMAOACYP2C19KDM1ACYP2B6 | |
| SCHEMBL25946465 | 0.87 | SMN1; SMN2 (0.47) | MAOBMAOACYP2C19KDM1ACYP2B6 | |
| Trifluoromethanesulfonic Acid SCHEMBL4169047 | 0.82 | KDM4E (0.46) | MAOBMAOACYP2C19KDM1ACYP2B6 | |
| Trifluoromethanesulfonic Acid SCHEMBL4169045 | 0.82 | KDM4E (0.46) | MAOBMAOACYP2C19KDM1ACYP2B6 | |
| SCHEMBL28625663 | 0.81 | CHRNA7 (0.50) | MAOBKDM1ATAAR1SLC6A2SLC6A3 | |
| SCHEMBL4790557 | 0.77 | SMN1; SMN2 (0.46) | MAOBMAOACYP2C19KDM1ACYP2B6 | |
| SCHEMBL17029481 | 0.76 | SLC6A2 (0.53) | CYP2C19CYP2D6SLC6A2ADRA1ASLC6A3 | |
| SCHEMBL13778756 | 0.76 | SLC6A2 (0.53) | CYP2C19CYP2D6SLC6A2ADRA1ASLC6A3 | |
| SCHEMBL4171302 | 0.76 | SMN1; SMN2 (0.44) | CYP2C19CYP1A2CYP2D6CYP2C9SLC6A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090170902-A1 | COMPOUNDS WHICH POTENTIATE GLUTAMATE RECEPTOR AND USES THEREOF IN MEDICINE | GLAXO GROUP LIMITED (GB) | 2009-07-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090170902-A1 | COMPOUNDS WHICH POTENTIATE GLUTAMATE RECEPTOR AND USES THEREOF IN MEDICINE | GRIN1, GRM1, GRIN2C | MAOB 2357/4885MAOA 2411/4885CYP2C19 2149/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.